This research proposal will focus on the determination of molecular and kinetic properties of four members of the CYP4A gene subfamily of rabbit cytochromes P450 that hydroxylate medium and/or long chain fatty acids and eIcosanoids primarily or exclusively in the omega-position. Cytochromes P4504A4, 4A5, 4A6 and 4A7 share 85% sequence identity at the amino acid level, yet their substrate specificities vary greatly. The physiological functions of these enzymes remain unclear but abundant literature documents their roles in hemodynamic regulation by controlling vascular tone. Cerebral and renal microvessels are contracted by omega-hydroxyarachidonic acid at concentrations of <10-10 M, for example. In the previous funding period these enzymes were cloned and expressed in E. coli using techniques unique to each isoform. It is now possible to prepare adequate quantities for experiments leading to the understanding of their functions. The generation of these closely related family members has permitted comparisons among them with respect to amino acid differences that could account for their substrate preferences. Also, a primary interest is the determination of the interactions of cytochrome b5 with these enzymes, which result in the marked activation of omega-hydroxylation activities. In order to understand these interactions, the following Specific Aims are proposed: 1) interactions of CYP4As with Substrate: Using the aforementioned expression systems, additional mutations of the various CYP4As wilt be constructed to compare the roles of unique, homologous and, in some cases, identical residues on the activities of the resulting proteins with respect to substrate specificity. The binding constants and rates of binding of various substrates to the CYP4As will be examined by stopped-flow spectrophotometry in the absence and presence of NADPHcytochrome P450 reductase and/or cytochrome b5. 2) Interactions of CYP4As with Other Proteins: Surface plasmon resonance (Biacore), stopped flow spectroscopic, Soret CD, and analytical ultracentrifugation methodologies will be used to examine the rates and thermodynamics of the binding of various expressed CYP4A subfamily members with their common redox partner, NADPH-cytochrome P450 reductase, in the presence and absence cytochrome b5. In addition, mutations of putative surface residues on the CYP4A sub-family members will attempt to map the binding sites for these proteins. 3) Electron Transfer/Acceptor Properties of CYP4A Monooxygenase System: The rates of electron flux NADPH-cytochrome P450 reductase and CYP4As will be measured by stopped-flow spectrophotometry at wavelengths specific for the flavins or heme prosthetic groups to determine the effects on electron transfer of cyt b5, using various substrates, specific to each CYP4A.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031296-22
Application #
6608868
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Ikeda, Richard A
Project Start
1990-07-01
Project End
2006-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
22
Fiscal Year
2003
Total Cost
$321,346
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Biochemistry
Type
Other Domestic Higher Education
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Sue Masters, Bettie; Marohnic, Christopher C (2006) Cytochromes P450--a family of proteins and scientists-understanding their relationships. Drug Metab Rev 38:209-25
Masters, Bettie Sue Siler (2005) The journey from NADPH-cytochrome P450 oxidoreductase to nitric oxide synthases. Biochem Biophys Res Commun 338:507-19
Loughran, P A; Roman, L J; Miller, R T et al. (2001) The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate. Arch Biochem Biophys 385:311-21
Aitken, A E; Roman, L J; Loughran, P A et al. (2001) Expressed CYP4A4 metabolism of prostaglandin E(1) and arachidonic acid. Arch Biochem Biophys 393:329-38
Loughran, P A; Roman, L J; Aitken, A E et al. (2000) Identification of unique amino acids that modulate CYP4A7 activity. Biochemistry 39:15110-20
Hosny, G; Roman, L J; Mostafa, M H et al. (1999) Unique properties of purified, Escherichia coli-expressed constitutive cytochrome P4504A5. Arch Biochem Biophys 366:199-206
Young, H M; O'Brien, A J; Furness, J B et al. (1997) Relationships between NADPH diaphorase staining and neuronal, endothelial, and inducible nitric oxide synthase and cytochrome P450 reductase immunoreactivities in guinea-pig tissues. Histochem Cell Biol 107:19-29
Zou, A P; Imig, J D; Ortiz de Montellano, P R et al. (1994) Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol 266:F934-41
Zou, A P; Ma, Y H; Sui, Z H et al. (1994) Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats. J Pharmacol Exp Ther 268:474-81
Zou, A P; Imig, J D; Kaldunski, M et al. (1994) Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 266:F275-82

Showing the most recent 10 out of 28 publications